1xbet 신청 Pharmaceutical Co., Ltd.

1xbet 신청 Pharmaceutical Co., Ltd. (1xbet 신청) and Axcelead Drug Discovery Partners Co., Ltd. (Axcelead) announce collaborative drug discovery research that will utilize the Axcelead Hit-identified Target (A-HiT) project in the area of central nervous system (CNS) diseases.

The two companies will jointly conduct lead generation and lead optimization research using candidates derived from the A-HiT project for drug discovery targets related to specific CNS diseases. The expectation is that the collaboration will expand 1xbet 신청's R&D pipeline.

Axcelead is the first comprehensive 1xbet 신청tegrated drug discovery solutions provider 1xbet 신청 the pharmaceutical 1xbet 신청dustry 1xbet 신청 Japan, hav1xbet 신청g succeeded some portion of the drug discovery research department of Takeda Pharmaceutical Company Limited. Axcelead commenced bus1xbet 신청ess 1xbet 신청 July 2017.

About Axceleadhttps://www.axcelead.com/en/